Healthcare -
Biotechnology - NASDAQ - US
$ 3.35
0.601 %
$ 2.33 M
Market Cap
0.0
P/E
RNAZ - OPERATING EXPENSES
Operating Expenses RNAZ - TransCode Therapeutics, Inc.
19.4 M
LAST VALUE
81.84%
2 YEAR CAGR
119.11%
5 YEAR CAGR
0.00%
10 YEAR CAGR